Compile Data Set for Download or QSAR
Report error Found 38 Enz. Inhib. hit(s) with all data for entry = 13165
TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764476(US20250255992, Compound 28)
Affinity DataIC50: 19nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764473(US20250255992, Compound 25)
Affinity DataIC50: 40nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764458(US20250255992, Compound 10)
Affinity DataIC50: 60nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764477(US20250255992, Compound 29)
Affinity DataIC50: 60nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764460(US20250255992, Compound 12)
Affinity DataIC50: 60nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764475(US20250255992, Compound 27)
Affinity DataIC50: 70nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764457(US20250255992, Compound 9)
Affinity DataIC50: 110nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764479(US20250255992, Compound 31)
Affinity DataIC50: 110nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764453(US20250255992, Compound 5)
Affinity DataIC50: 130nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764474(US20250255992, Compound 26)
Affinity DataIC50: 160nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764456(US20250255992, Compound 8)
Affinity DataIC50: 190nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764464(US20250255992, Compound 16)
Affinity DataIC50: 310nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764468(US20250255992, Compound 20)
Affinity DataIC50: 540nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764452(US20250255992, Compound 4)
Affinity DataIC50: 590nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764449(US20250255992, Compound 1)
Affinity DataIC50: 1.21E+3nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764450(US20250255992, Compound 2)
Affinity DataIC50: 1.33E+3nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764472(US20250255992, Compound 24)
Affinity DataIC50: 1.39E+3nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764462(US20250255992, Compound 14)
Affinity DataIC50: 2.36E+3nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764463(US20250255992, Compound 15)
Affinity DataIC50: 2.37E+3nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764469(US20250255992, Compound 21)
Affinity DataIC50: 2.48E+3nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764454(US20250255992, Compound 6)
Affinity DataIC50: 3.31E+3nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764465(US20250255992, Compound 17)
Affinity DataIC50: 4.15E+3nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764470(US20250255992, Compound 22)
Affinity DataIC50: 4.41E+3nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764471(US20250255992, Compound 23)
Affinity DataIC50: 4.43E+3nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764459(US20250255992, Compound 11)
Affinity DataIC50: 4.49E+3nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764467(US20250255992, Compound 19)
Affinity DataIC50: 4.51E+3nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764478(US20250255992, Compound 30)
Affinity DataIC50: 6.05E+3nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 1(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764475(US20250255992, Compound 27)
Affinity DataIC50: 1.00E+4nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 1(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764464(US20250255992, Compound 16)
Affinity DataIC50: 1.00E+4nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764451(US20250255992, Compound 3)
Affinity DataIC50: 1.00E+4nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764455(US20250255992, Compound 7)
Affinity DataIC50: 1.00E+4nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 1(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764476(US20250255992, Compound 28)
Affinity DataIC50: 1.00E+4nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764461(US20250255992, Compound 13)
Affinity DataIC50: 1.00E+4nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 1(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764453(US20250255992, Compound 5)
Affinity DataIC50: 1.00E+4nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764479(US20250255992, Compound 31)
Affinity DataIC50: 1.00E+4nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 1(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764460(US20250255992, Compound 12)
Affinity DataIC50: 1.00E+4nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 1(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764458(US20250255992, Compound 10)
Affinity DataIC50: 1.00E+4nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent

TargetProstaglandin G/H synthase 2(Human)
Reiley Pharmaceuticals

US Patent
LigandPNGBDBM764466(US20250255992, Compound 18)
Affinity DataIC50: 1.00E+4nMAssay Description:The ability of compounds to inhibit ovine COX-1 and human COX-2 is determined using a commercially available enzyme immunoassay (EIA) kit (catalog no...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
11/24/2025
Entry Details
US Patent